Dr. Elias Zerhouni, the first radiologist to serve as director of the National Institutes of Health, envisions a central role for medical imaging in 21st century medical research and practice. He predicted growth for image-guided therapies, imaging genomics, computer-based radiology applications, and molecular imaging during a lecture at the 2006 International Society for Magnetic Resonance in Medicine meeting in Seattle.
Dr. Elias Zerhouni, the first radiologist to serve as director of the National Institutes of Health, envisions a central role for medical imaging in 21st century medical research and practice. He predicted growth for image-guided therapies, imaging genomics, computer-based radiology applications, and molecular imaging during a lecture at the 2006 International Society for Magnetic Resonance in Medicine meeting in Seattle.
Breakthroughs that have transformed medicine rely on discoveries made at the juncture of scientific disciplines, he said. The application of computers to imaging revolutionized radiology. Real-time cine pushed cardiac imaging forward, and television adopted for x-ray technology led to interventional radiology. Imaging is no longer simply a method for creating images, but a method of extracting information for all physical scales from single molecules to the full organ.
"Today, biology is again driving new research, be it genomics or proteomics or targeted agents," Zerhouni said. "In this century, we will have to intervene before the damage is done. We need to preserve normal function, and our ability to detect patients at risk is increasing remarkably."
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.